New Cellular Pathway Controlling p53, the Guardian of the Genome, Discovered

In more than % 50 of human cancers, the p53 gene is mutated . Although it is the most studied and best-known gene, the molecular pathways controlling p53 have not yet been fully elucidated. In this context, in March 2019, Nature Cell Biology published a study discovering a new enzyme pathway that controls p53. This advance may enable the development of effective drugs targeting p53.
p53 is one of the most important tumor suppressor genes in our body. When DNA damage occurs in a cell, it initiates repair. If the damage is beyond repair, it initiates apoptosis (programmed cell death), eliminating the cell. Because of its importance in maintaining genetic integrity, p53 is known as the guardian of the genome . When p53 mutates, DNA damage begins to accumulate in the cell. This subsequently leads to cancer. In most human cancers, p53 is mutated. Cancer follows an aggressive course in patients with p53 mutations. To date, an effective drug against p53 has not been developed.
The research was conducted at the University of Winconsin-Madison in the United States. Cellular pathways controlling the p53 gene were examined.
According to the Research Results;
- The PIPK1-alpha enzyme and the secondary lipid carrier PIP2 were discovered to be fundamentally important in controlling p53.
The figure below illustrates how heat shock proteins and PIPKI-α stabilize p53.

When a cell is under stress from DNA damage or other causes, the PIP1K-alpha enzyme binds to p53 and produces PIP2. PIP2 enables p53 and small heat shock proteins to bind more strongly. This protein stabilization leads to aggressive cancers such as triple-negative breast cancer .
Small heat shock proteins are very important for stabilizing other proteins. Heat shock proteins binding to mutant p53 take on a cancer-promoting role. Another important finding was that;
- when the PIP2 enzyme pathway was disrupted, mutant p53 did not accumulate or cause damage.
What Does This Study Mean for Us?
- A critical pathway regulating p53 was discovered.
- Eliminating mutant p53 may also enable the prevention of p53-related cancers.
- Researchers are focusing on designing inhibitors (suppressors) for the PIPK1-alpha enzyme. These inhibitors may offer an effective treatment for tumors with p53 mutations.
Sources
A nuclear phosphoinositide kinase complex regulates p53.
Nature Cell Biology, 18 March 2019
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.